Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2008
10/07/2008US7432096 Glucose dehydrogenase and production thereof
10/07/2008US7432095 Enzymatic polypeptide which is functionally active in presence of ethyl 4-chloroacetoacetate for use in regenerating coenzymes in an enzymatic reduction system; cyclic generation of preferential compounds
10/07/2008US7432094 Glucose dehydrogenase β subunit and DNA encoding the same
10/07/2008US7432090 Blocking sporulation by inhibiting SpoIIE
10/07/2008US7432089 Biosynthesis; introducing DNA encoding given enzyme into Sinorhizobium or Escherichia cell; raw material for medicines, feed additives
10/07/2008US7432083 Method for in vitro molecular evolution of protein function
10/07/2008US7432082 Using polymerase chain recation amplification to identify allelic variation in acetohydroxy acid synthase (AHASL) gene; preparing transgenic plants with enhanced herbicide resistance
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7432063 Selecting antibodies with enhanced affinity for an antigen relative to a reference antibody; immunodiagnostics and competetive binding
10/07/2008US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
10/07/2008US7432057 Amplifying genomic nucleic acid with primers and visualizing on gel for genotyping; better meat quality, higher postmortem pH and better water holding capacity
10/07/2008US7432056 Determining frequency of an eicosanoid-related and/or 12-lipoxygenase gene sequence within a population; diagnosing and treating inflammatory diseases
10/07/2008US7432054 Method for separating and purifying a nucleic acid
10/07/2008US7432053 Fluorescent protein from Aequorea coerulscens and methods for using the same
10/07/2008US7432052 Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders
10/07/2008US7432050 Methods and compositions for detecting colon cancers
10/07/2008US7431926 Tumor supressor gene p33ING2
10/07/2008CA2277198C Stabilized aqueous nucleoside triphosphate solution
10/07/2008CA2256606C Procedure for subtractive hybridization and difference analysis
10/07/2008CA2209426C Human pak65
10/07/2008CA2173956C Dna encoding 1,3-beta-d glucan synthase subunits
10/07/2008CA2173100C Device for isolating nucleic acids
10/07/2008CA1341582C Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
10/02/2008WO2008119084A1 Method for identifying and selecting low copy nucleic acid segments
10/02/2008WO2008118843A2 Arrays, systems, and methods of using genetics predictors of polycystic diseases
10/02/2008WO2008118786A1 Methods and biomarkers for detecting nanoparticle exposure
10/02/2008WO2008118507A2 Recombinant human factor ix and use thereof
10/02/2008WO2008116265A1 Peptides with anitfungal activity
10/02/2008WO2008084254A3 Cell line for alzheimer's disease therapy screening
10/02/2008WO2008067070A3 Compositions and methods for producing benzylisoquinolines alkaloids
10/02/2008WO2008063291A3 Polypeptide ligands for targeting cartilage and methods of use thereof
10/02/2008WO2008060363A3 Tumor associated markers in the diagnosis of prostate cancer
10/02/2008WO2008060362A3 Methods and compositions for the treatment of skin diseases and disorders
10/02/2008WO2008051505A8 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
10/02/2008WO2008037568A3 Reversible terminators for efficient sequencing by synthesis
10/02/2008WO2008021140A3 Recombinant aav production in mammalian cells
10/02/2008WO2008013996A3 Engineered microorganisms for increasing product yield in biotransformations, related methods and systems
10/02/2008WO2007150036A3 Episomal expression vector for metazoan cells
10/02/2008WO2007133654A3 Two pore channels as regulators of proliferation in cancer
10/02/2008WO2007120343A3 Heat shock rna and its use
10/02/2008WO2007118245A8 Methods and compositions related to adenoassociated virus-phage particles
10/02/2008WO2007095398A3 Xylanases, nucleic acids encoding them and methods for making and using them
10/02/2008WO2007092182A3 Rna interference agents for therapeutic use
10/02/2008WO2007078457A3 Compositions and methods for the detection of a nucleic acid using a cleavage reaction
10/02/2008WO2007055735A3 Hydrolases, nucleic acids encoding them and methods for making and using them
10/02/2008WO2007016591A3 Compositions and methods for monitoring and altering protein folding and solubility
10/02/2008WO2006084051A3 Use of id4 for diagnosis and treatment of cancer
10/02/2008WO2005072340A3 Novel polynucleotides encoding polypeptides and methods using same
10/02/2008US20080244793 Brassica napus late embryogenesis abundant (Lea) protein genetic enhancers comprising a DNA sequence which selectively promotes gene expression in a plant seed and/or in vegetative tissues for early detection of gene expression
10/02/2008US20080244791 Tuber preferential regulatory sequences for use in generating plants with enhanced nitrogen fixation and resistance to soil borne pathogens
10/02/2008US20080242851 Modified polynucleotides for reducing off-target effects in rna interference
10/02/2008US20080242843 Function of a haptoglobin-haemoglobin receptor and the uses thereof
10/02/2008US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders
10/02/2008US20080242630 Fusion proteins of mycobacterium tuberculosis
10/02/2008US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes
10/02/2008US20080242628 In vivo
10/02/2008US20080242625 Nucleotide-Cochleate Compositions And Methods Of Use
10/02/2008US20080242623 Microutrophin and Uses Thereof
10/02/2008US20080242617 Two component bacillus lantibiotic and methods for producing and using the same
10/02/2008US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain
10/02/2008US20080242607 Glycosylation of peptides via o-linked glycosylation sequences
10/02/2008US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent
10/02/2008US20080242603 Interleukins; genetic engineering; vectors and host cells; anticancer agents; immunology diseases; infections; antiischemic agents; antitumor agents
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention
10/02/2008US20080242562 Apparatus and methods for detecting nucleic acid in biological samples
10/02/2008US20080242554 Nucleotide primer set and nucleotide probe for detecting genotype of methylene tetrahydrofolate reductase (mthfr)
10/02/2008US20080242547 Chimeric promoters for use in plants
10/02/2008US20080241947 Nucleotide sequences coding proton-coupled folate transporter (PCFT) for used in treatment and prevention of folate malabsorption disorders
10/02/2008US20080241928 Methods and compositions for acid phosphatase-1 gene inhibition
10/02/2008US20080241927 Novel glyphosate-n-acetyltransferase (gat) genes
10/02/2008US20080241899 Poly (3-Hydroxyalkanoate) Block Copolymer Having Shape Memory Effect
10/02/2008US20080241895 N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene
10/02/2008US20080241893 Using protozoan specific primers to cyclicly replicate preferential nucleotide sequences
10/02/2008US20080241892 Modified surfaces for immobilization of active molecules
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241881 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells
10/02/2008US20080241880 Methods and compositions for determination of glycated proteins
10/02/2008US20080241867 Expression vector comprising nucleotide sequences coding reporter protein/protease cleavage sequence fusion; detecting enzymatic activity in solution
10/02/2008US20080241866 Systems and methods for enhancing fluorescent signals
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241833 Using primer extension to determine sequence of single nucleotide polymorphism; gene expression analysis
10/02/2008US20080241832 Using single straned RNA amplification as evaluative tool in diagnosing hepatitis viral load
10/02/2008US20080241826 Probe And Primer For Tubercle Bacillus Detection, And Method Of Detecting Human Tubercle Bacillus Therewith
10/02/2008US20080241824 Mutation Associated With Lacunar Strokes
10/02/2008US20080241818 Method and microarray for detecting herpesviruses
10/02/2008US20080241198 Selective angiogenesis and gene expression inhibition of the vascular endothelial growth factor pathway; ocular disease; antiarthritic, antiinflammatory agents
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241172 Mutated Cholinesterase Sequences, Corresponding Nucleic Acids And Their Uses
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM